Provided by Tiger Trade Technology Pte. Ltd.

WAVE Life Sciences

6.37
+0.16502.66%
Post-market: 6.400.0350+0.55%19:56 EDT
Volume:13.49M
Turnover:86.96M
Market Cap:1.20B
PE:-5.25
High:6.74
Open:6.02
Low:6.00
Close:6.20
52wk High:21.73
52wk Low:5.02
Shares:188.25M
Float Shares:157.87M
Volume Ratio:1.02
T/O Rate:8.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2118
EPS(LYR):-1.2118
ROE:-54.97%
ROA:-27.18%
PB:2.31
PE(LYR):-5.25

Loading ...

Wave Life Sciences Ltd - to Initiate Phase 2a Inlight and New Wve-007 Trials as Incretin Add-on in 2026

THOMSON REUTERS
·
Mar 26

Wave Life Sciences Ltd: Additional Data From Inlight, Including Data From 600 Mg Phase 1 Sad Cohort, Are Expected in 2026

THOMSON REUTERS
·
Mar 26

Wave Life Sciences Ltd - Wve-007 Continues to Be Generally Safe and Well Tolerated

THOMSON REUTERS
·
Mar 26

Wave Life Sciences reports Phase 1 INLIGHT interim data; WVE-007 cuts visceral fat 14.3% at 6 months after a single 240 mg dose

Reuters
·
Mar 26

Wave Life Sciences Ltd : Mizuho Raises Target Price to $27 From $22

THOMSON REUTERS
·
Mar 25

Mizuho Securities Reaffirms Their Buy Rating on Wave Life Sciences (WVE)

TIPRANKS
·
Mar 25

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pfizer (PFE) and Wave Life Sciences (WVE)

TIPRANKS
·
Mar 24

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE), Wave Life Sciences (WVE) and Telix Pharmaceuticals (OtherTLPPF)

TIPRANKS
·
Mar 16

Wave Life Sciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Mar 11

Wave Life Sciences price target raised to $52 from $43 at Canaccord

TIPRANKS
·
Mar 10

Wave Life Sciences Ltd : Canaccord Genuity Raises Target Price to $52 From $43

THOMSON REUTERS
·
Mar 10

Wave Life Sciences Is Maintained at Outperform by Wedbush

Dow Jones
·
Mar 06

Wedbush Adjusts Wave Life Sciences PT to $35 From $33, Maintains Outperform Rating

MT Newswires Live
·
Mar 06

Wave Life Sciences price target raised to $35 from $33 at Wedbush

TIPRANKS
·
Mar 06

Wave Life Sciences to present late-breaking WVE-006 RestorAATion-2 data at ATS International Conference

Reuters
·
Mar 05

Wave Life Sciences Obesity Proof Of Concept Sparks Focus On Pipeline Upside

Simply Wall St.
·
Mar 04

Wave Life Sciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 02

Wave Life Sciences SVP Chris Francis Disposes of Common Shares

Reuters
·
Feb 28

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE) and Kymera Therapeutics (KYMR)

TIPRANKS
·
Feb 28

Stock Track | WAVE Life Sciences Plummets 5.03% Intraday Following Analyst Ratings Release

Stock Track
·
Feb 27